Conmed Corporation · NYSE:CNMD
Conmed — Investor Presentation (November 2022)
10 slides from Conmed's investor presentation, Nov 15, 2022
Slide 1: Investor Presentation
Investor Presentation Curt R. Hartman Chair of the Board, President, and Chief Executive Officer Todd W. Garner Executive Vice President and Chief Financial Officer November 15, 2022 Exhibit 99.2
Slide 2: Forward-Looking Information
Forward-Looking Information This presentation contains forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 199
Slide 3: CONMED Vision
CONMED Vision Empower healthcare providers worldwide to deliver exceptional outcomes for patients. Focus behind the Vision People, Products, Profitability
Slide 4: Objectives for Our Shareholders
Objectives for Our Shareholders Aggregate growth and profitability over the long term to significantly increase the valuation of the company Increase our market share in large and attractive markets Deliver above-market revenue and profitability growth over the long term
Slide 5: Higher-Growth Products
Higher-Growth Products Continuing to Shift the Mix of the Portfolio to Higher-Growth Products 2015 * YTD Sep 2019 * YTD Sept 2022 Products Declining 79% 17% 16% Products Growing Single Digits 21% 48% 42% Products Growing Double Digits 0% 35% 42% * Denotes latest disclosure of this metric at J.P. Mor
Slide 6: Navigating Temporary Challenges to an Improved Engine
Navigating Temporary Challenges to an Improved Engine Q4 Update: Implemented a Warehouse Management Software System in Q4 2022 that will increase capacity and efficiency Shipping delays resulting from this implementation have been longer than anticipated but should be contained to Q4 2022 The Compan
Slide 7: Orthopedics: Large, Attractive Markets
Orthopedics: Large, Attractive Markets Category Description Market Size and Competitors Dollar Value of 1 Market Share Point Sports Medicine Devices for repair of soft tissue injuries in joints $4.4 to $4.6 Billion ~$45M Arthrex DePuy Mitek (J&J) Smith & Nephew Stryker Zimmer Biomet Allograft Tissue
Slide 8: General Surgery: Large, Attractive Markets
General Surgery: Large, Attractive Markets Category Description Market Size and Competitors Dollar Value of 1 Market Share Point Access A platform of devices and accessories to create and enter the surgical working space in minimally invasive procedures $1.4 to $1.6 Billion ~$15M Ethicon (J&J) Appli
Slide 9: Environmental, Social and Governance (ESG)
Environmental, Social and Governance (ESG) Together We Are Making A Difference for a Better Tomorrow Environmental Chihuahua, Mexico plant has held the Clean Industry Certification since 2015 Utica, New York plant is ISO 14001 certified 100% LED lighting at Utica and Chihuahua plants Social Partners
Slide 10: Closing Thoughts
Closing Thoughts Intense focus on solving unmet needs for healthcare customers drives increased market share Large and attractive markets provide CONMED with ample opportunities for above-average revenue and profitability growth Aggregating growth over the long term can drive meaningful shareholder